NLSP icon

NLS Pharmaceutics
NLSP

Overview Fund Activity

5 hedge funds and large institutions have $335K invested in NLS Pharmaceutics in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$156K
2
Two Sigma Advisers
2
Two Sigma Advisers
New York
$68K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$35K
4
TSS
4
Two Sigma Securities
New York
$25K
5
Citadel Advisors
5
Citadel Advisors
Florida
$51K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
1
UBS Group
Switzerland
$156K +$151K +1,514 +3,154%
Two Sigma Advisers
2
Two Sigma Advisers
New York
$68K +$41.1K +413 +153%
Citadel Advisors
3
Citadel Advisors
Florida
$51K +$24.7K +247 +94%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$35K +$35K +359 New
TSS
5
Two Sigma Securities
New York
$25K +$25K +254 New
Renaissance Technologies
6
Renaissance Technologies
New York
– -$132K -1,050 Closed